| Accueil |  |
|
Publications 2005
2/12/08
|
||||
| Delacourte A. The natural history of Alzheimer's disease. Alzheimer 100 | ||||
|
||||
| Delacourte A. Alzheimer’s disease: a true tauopathy fueled by amyloid precursor protein dysfunction. Chapter 39. Recent progress in Alzheimer's and Parkinson's disease. Edited by I Hanin, R Cacabelos, A. Fisher. | ||||
|
||||
| Delacourte A. Le vieillissement cérébral | ||||
|
||||
|
||||
Delobel P, Leroy O, Hamdane M, Sambo AV, Delacourte A, Buee L. Proteasome inhibition and Tau proteolysis: an unexpected regulation. |
||||
| Hamdane M, Bretteville A, Sambo AV, Schindowski K, Begard S, Delacourte A, Bertrand P, Buee L. p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death. |
||||
|
||||
|
||||
|
Expression of human FE65 in amyloid precursor protein transgenic mice is associated with a reduction in beta-amyloid load. J Neurochem. 2005 Apr;93(2):330-8. PMID: 15816856 |
||||
Tau protein as a differential biomarker of tauopathies |
||||
Vingtdeux V, Hamdane M, Gompel M, Begard S, Drobecq H, Ghestem A, Grosjean ME, Kostanjevecki V, Grognet P, Vanmechelen E, Buee L, Delacourte A, Sergeant N. Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism. Neurobiol Dis. 2005 Nov;20(2):625-37. Epub 2005 Jun 3. PMID: 15936948 [PubMed - indexed for MEDLINE] |
||||
|
||||
|
